» Articles » PMID: 39407984

Radiation Exposure with Self-Expandable Metallic Stent Versus Transanal Decompression Tube for Malignant Colorectal Obstruction: A Post Hoc Propensity Score Matched Analysis

Abstract

Although several reports have compared the outcomes of self-expandable metallic stent (SEMSs) and transanal decompression tube (TDT) placement for malignant colorectal obstruction (MCO), few studies have compared the radiation exposure (RE) associated with these two procedures. Consequently, we aimed to compare the RE of SEMS and TDT placements for MCO using propensity score matching (PSM) in a multi-center, prospective observational study. This study investigated the clinical data of 236 patients who underwent SEMS or TDT placement. The air kerma at the patient entrance reference point (K: mGy) and air kerma-area product (P; Gycm) were measured and compared between SEMS and TDT groups after PSM. After PSM, 61 patients were identified in each group. The median K in the SEMS group was significantly greater than that in the TDT group (77.4 vs. 55.6 mGy; = 0.025) across the entire cohort. With respect to subgroup analyses by location, in the rectum, the median K and P were significantly greater in the SEMS group than in the TDT group (172.9 vs. 34.6 mGy; = 0.001; and 46.0 vs. 18.1 Gycm; = 0.006, respectively). However, in the colon, the RE parameters did not significantly differ between the two groups. TDT might be a more suitable option for decompression in patients with malignant rectal obstruction due to its lower RE and technical advantages. Conversely, SEMS placement is recommended as the first decompression method to treat malignant colonic obstruction, in line with the current guidelines.

References
1.
Takeyama H, Kitani K, Wakasa T, Tsujie M, Fujiwara Y, Mizuno S . Self-expanding metallic stent improves histopathologic edema compared with transanal drainage tube for malignant colorectal obstruction. Dig Endosc. 2015; 28(4):456-464. DOI: 10.1111/den.12585. View

2.
. Colorectal Endoscopic Stenting Trial (CReST) for obstructing left-sided colorectal cancer: randomized clinical trial. Br J Surg. 2022; 109(11):1073-1080. DOI: 10.1093/bjs/znac141. View

3.
Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T . Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2019; 25(1):1-42. PMC: 6946738. DOI: 10.1007/s10147-019-01485-z. View

4.
Kuwai T, Tamaru Y, Kusunoki R, Yoshida S, Matsuzawa T, Isayama H . Long-term outcomes of standardized colonic stenting using WallFlex as a bridge to surgery: Multicenter prospective cohort study. Dig Endosc. 2021; 34(4):840-849. PMC: 9293325. DOI: 10.1111/den.14137. View

5.
Kanda Y . Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2012; 48(3):452-8. PMC: 3590441. DOI: 10.1038/bmt.2012.244. View